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キーワード：ボツリヌス毒素 CRPS  運動感覚障害 発汗異常           
 
 
It is known that motor disturbance is a rare complication of complex regional pain syndrome (CRPS). The patient 
was a 40 years man suffered from right digitus anularis damage for work accident. He was complaint of pain and 
numbness in an early stage. 1 years later, He came to appeal for right hand rigidity, sensory loss and excessive 
diaphoresis.  
We diagnosised local dystonia and dyshydosis related with CRPS after injury. Rehabilitation under epidural 
continuous block , intravenous regional steroid and stellate ganglion block were carried out hospitalization at 
first. However his symptoms were no change. Botulinum toxin was injected intramuscularly 2.5～10 units/site 
into the muscle rigidity area (total dose 75 units)  Five days later, Muscle rigidity were disappeared gradually, 
and sensory level and diaphoresis were recovered approximately completely. We supposed that a botulinum toxin 
treatment of a periphery level had an influence on central plasticity to improve local motor-sensory disturbance 
and dyshidrosis.  
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これまで CRPS との関連でのボツリヌス治療の報告は 37
人の上肢ジストニア、スパズムを合併した CRPS 患者に
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